SARS-COV-2 infection biomarkers and uses thereof
Abstract:
Disclosed herein are methods that employ the use of one or more biomarkers for the treatment of SARS-CoV-2 infected individuals (COVID-19 patients). The methods may employ detection and measurement of one or more cytokines, the measurement of which may be used to treat COVID-19 patients with one or more immunomodulatory therapies.
Public/Granted literature
Information query
Patent Agency Ranking
0/0